Advances & Updates
PNOC001: Phase II Study of Everolimus For Recurrent or Progressive Low-Grade Gliomas in Children
Machine learning to identify LGG subgroups
Connect with PNOC
Collaboration is a key part of PNOC’s values and our success. We collaborate with individuals, hospitals, research institutions, patients and families – with anyone. Contact us if you have an idea or question, or if you would like to learn more about collaborating with us.